Thrombectomy devices play a crucial role in the treatment of pulmonary embolisms and peripheral arterial diseases. These devices are available in various sizes and diameters, catering to specific affected areas. Surgical embolectomy, balloon embolectomy, and aspiration embolectomy are among the commonly used procedures using thrombectomy devices. Explore the advancements and applications of thrombectomy devices in the treatment of these conditions for improved patient outcomes.
According to Data Bridge Market Research, the Thrombectomy Devices Market accounted for USD 1.3 billion in 2022, would rocket up to USD 2.06 billion by 2030, and is expected to undergo a CAGR of 5.9% during the forecast period 2023 to 2030.
“Growing numbers of cardiac cases”
The increasing prevalence of cardiac conditions, such as acute ischemic stroke and deep vein thrombosis, has created a growing demand for thrombectomy devices. These devices are designed to remove blood clots from blocked arteries or veins, restoring blood flow and preventing further complications. As the need for effective and minimally invasive treatment options rises, which is driving the market growth of thrombectomy devices.
What restraints the growth of thrombectomy devices market?
“High-cost devices limit market growth”
The high cost associated with thrombectomy devices can have a negative impact on the thrombectomy device market. The high cost of these devices can limit their affordability and accessibility, especially in healthcare systems with budget constraints. This can result in lower adoption rates and slower market growth. Additionally, the high cost may deter healthcare facilities from investing in these devices, leading to limited availability and reduced utilization in clinical settings.
Segmentation: Thrombectomy Devices Market
The thrombectomy devices market is segmented on the basis of product type, application, end-user and distribution channel.
- On the basis of product type, the thrombectomy devices market is segmented into aspiration thrombectomy devices, ultrasonic thrombectomy devices, mechanical thrombectomy devices and, others.
- On the basis of application, the thrombectomy devices market is segmented into cardiovascular thrombectomy, neurovascular thrombectomy, and peripheral vascular thrombectomy.
- On the basis of end-user, the thrombectomy devices market is segmented into hospitals, trauma centres, ambulatory surgical centres and other.
- On the basis of distribution channel, the thrombectomy devices market is segmented into direct tender and retail sales.
Regional Insights: North America dominates the thrombectomy devices market
North America dominates the thrombectomy devices market due to the pervasiveness of numerous pharmaceuticals and biotechnology companies, coupled with the rapid pace of technological advancements and a growing geriatric population.
The Asia-Pacific region is anticipated to exhibit the highest growth rate from 2023 to 2030. This growth is primarily driven by factors such as the increasing number of geriatric population and the rise in disposable income among individuals in the region.
To know more about the study visit, https://www.databridgemarketresearch.com/de/reports/global-thrombectomy-devices-market
Recent Developments in Thrombectomy Devices Market
- In 2022, EMBOGUARD, the next-generation balloon guide catheter by Cernuous, a part of Johnson & Johnson Medical Devices Companies, was introduced. This innovative catheter is designed for use in endovascular procedures for patients with acute ischemic stroke.
- In 2021, The CHEETAH clinical study conducted by Penumbra Inc. showcased positive outcomes for the Indigo System CA RX Catheter. Meeting its primary endpoint, the study demonstrated high rates of blood flow restoration, blood clot removal, and myocardial perfusion in patients with high thrombus burden undergoing percutaneous coronary intervention (PCI).
The Prominent Key Players Operating in the Thrombectomy Devices Market Include:
- Medtronic (Ireland)
- Inari Medical, Inc (U.S.)
- AngioDynamics (U.S.)
- Terumo Corporation (Japan)
- Stryker (U.S.)
- Zimmer Biomet (U.S.)
- Boston Scientific Corporation (U.S.)
- BD (U.S.)
- Straub Medical AG (Switzerland)
- Penumbra, Inc (U.S.)
- Edwards Lifesciences Corporation (U.S.)
- ARGON MEDICAL. (U.S.)
- Teleflex Incorporated (U.S.)
- phenox GmbH (Germany)
- Acandis GmbH (Germany)
- Merit Medical Systems (U.S.)
- Bayer AG (Germany)
- Getinge AB (Sweden)
- Philips Healthcare (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of thrombectomy devices market companies contact, https://www.databridgemarketresearch.com/de/contact
Research Methodology: Global Thrombectomy Devices Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
